Petition - National Health Funding for Low Dose Naltrexone in Australia

http://www.gopetiti on.com/online/ 28354.html

National Health Funding for Low Dose Naltrexone in Australia

Published by Trevor George Stephens
Date: Jun 06, 2009
Category: Health
Region: Australia
Target: Cancer sufferers MS sufferers and HIV+ persons
Web site: http://www.lowdosen altrexone. org/

Low Dose Naltrexone (LDN) Dose Timing

http://ms.about.com/b/2009/07/20/julies-low-dose-naltrexone-faqs-dose-timing.htm

UK LDN Now Day - Saturday 12th September 2009

On LDN Now Day, volunteers will be soliciting signatures for the Number 10 LDN Petition -

http://petitions.number10.gov.uk/LowDNaltrexone/

Read more on the LDN Now Blog here -

http://ldnnow.co.uk/8601.html?entryId=4c926df35035815d4caacb2f4a7a11c0

And search for #ldnnowday on twitter for more info as it is available.

http://twitter.com/LD_Naltrexone

Multiple Sclerosis Drug Prices and Low Dose Naltrexone (LDN)

Looking at this article about MS drug prices in the US really brings it home how much the UK NHS could save using Low Dose Naltrexone (LDN) for MS treatment -

"

• Avonex (was $10,000/year): Minimum price = $23,736; Maximum price = $30,660
• Betaseron (was $10,000/year): Minimum price = $22,272; Maximum price = $32,616
• Copaxone (was $10,000/year): Minimum price = $23,208; Maximum price = $33,804
• Rebif was (was $15,600/year): Minimum price = $25,068; Maximum price = $30,756
• Tysabri (was $28,400/year): Now costs 31,332 for the drug itself, with additional charges for the infusion facility or clinic fees."

Article -

http://ms.about.com/b/2009/07/21/multiple-sclerosis-drug-prices-whoa.htm

Low Dose Naltrexonxe (LDN) on the Fourth Plinth, Trafalgar Square, London

http://www.oneandother.co.uk/participants/Brian_L/

Video - Dr Bernard Bihari Interviewed on Low Dose Naltrexone (LDN)

Low Dose Naltrexone from Fertility Care on Vimeo.

Video - MS Patient on Symptom Improvement on Low Dose Naltrexone (LDN), Contrasted with Tysbari

Video - MS Patient on Low Dose Naltrexone (LDN) Stopping Progression

Video - Skip Lenz, LDN (Low Dose Naltrexone) Expert Pharmacist on LDN Side Effects (Lack of)

Video - Skip Lenz, LDN (Low Dose Naltrexone) Expert Pharmacist

Video - 40 Year Crohn's Patient Tells of Her LDN Experience

Low Dose Naltrexone (LDN) on The Fourth Plinth, Trafalgar Square, London, Friday July 22nd 2009

This Friday, 22nd of July between 11:00-12:00, Brian Lonsdale will be on the Fourth Plinth in Trafalgar Square, London to focus attention on Low Dose Naltrexone and specifically, the Number 10 petition -

UK Government Petition for Low Dose Naltrexone Trial Funding

Trafalgar Square, Fourth Plinth Web Site

Milford Haven woman petitions government for LDN (Low Dose Naltrexone) trials

Article from The Western Telegraph Newspaper

"Jayne Crocker and her partner Andrew Barnett are both prescribed low dose naltrexone (LDN). They say the generic drug has been used to successfully treat cancer, autoimmune systems and central nervous system disorders. "

http://bit.ly/EVfQm

(MS) Sufferer joins in battle for trials of 'wonder drug' (Low Dose Naltrexone)

Article from This Is South Wales web site -

"The couple have created a petition to take their fight to 10 Downing Street, and have already gathered around 3,000 signatures.

Mr Barnett, who has secondary progressive MS, said: "We urge the Government to fund a trial of LDN on the NHS."

http://bit.ly/3Iy3sI

MS Patient Blog - On Low Dose Naltrexone (LDN) She Forgets She Has MS

The latest installment of Julie Stachowiak, Ph.D.'s Low Dose Naltrexone experience with Relapsing Remitting Multiple Sclerosis.

In this entry Julie says that, at times she is starting to forget she has MS due to the beneficial effect of LDN.

http://ms.about.com/b/2009/07/07/julies-low-dose-naltrexone-journal-month-2-5.htm

Glutamate and Low Dose Naltrexone (LDN) and MS

"Glutamate excess and its reduction by low dose naltrexone (LDN) are the main facets of the hypothesis proposed by the Cornell pathologist Yash Agrawal in explaining the benefits of LDN described in MS (anecdotally and in clinical trials). In his research, Dr. John Hong a senior scientists at the National Institutes of Health, has shown how glutamate contributes to the disease process in Parkinson’s Disease. In his preliminary studies of low dose opiate antagonists such as naltrexone, Dr. Hong has also shown how these compounds reduce glutamate accumulations and stop disease progression in neurological disorders."

http://autoimmunedisease.suite101.com/article.cfm/glutamate_excess_in_multiple_sclerosis_variants

Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study

"Results. Low-dose naltrexone reduced fibromyalgia symptoms in the entire cohort, with a greater than 30% reduction of symptoms over placebo. In addition, laboratory visits showed that mechanical and heat pain thresholds were improved by the drug. Side effects (including insomnia and vivid dreams) were rare, and described as minor and transient. Baseline erythrocyte sedimentation rate predicted over 80% of the variance in drug response. Individuals with higher sedimentation rates (indicating general inflammatory processes) had the greatest reduction of symptoms in response to low-dose naltrexone."

http://www3.interscience.wiley.com/journal/122350858/abstract?CRETRY=1&SRETRY=0